Today's applications require monitoring, logging, configuration, etc. Each of these concerns can be implemented as a ...

Total test volumes grew 29% year over year due to increased adoption from both pulmonology and primary care, with test ...

Q1 2026 earnings call: 42% revenue growth, margin expansion, Nodify Lung adoption and raised 2026 guidance to $108–$114M—read now.

Evidence suggests that adoption of oncology biosimilars in Medicare value-based payment models has produced substantial cost ...

Full-year revenue guidance was raised to $108 million to $114 million, reflecting strong Q1 performance and improved ...

Billiontoone (NASDAQ:BLLN) reported first-quarter 2026 results showing rapid revenue growth alongside GAAP profitability, driven by higher test volumes, rising average selling prices (ASPs), and ...

Detailed price information for Billiontoone Inc Cl A (BLLN-Q) from The Globe and Mail including charting and trades.

Technology Commercialization Leader Expected to Enhance QLE's Government Partnerships and Advanced Materials Strategy ...

Event: Caris First Quarter 2026 Financial Results Conference Call Date: Thursday, May 7, 2026 Time: 3:30 p.m. CT (4:30 p.m.

Q1 2026 Earnings Call May 6, 2026 4:30 PM EDTCompany ParticipantsAdam Grossman - Co-Founder, President, CEO & DirectorP.

Surat (Gujarat) [India], May 7: TestGrid, a leading provider of AI for software testing, test infrastructure and automation solutions, has been awarded the Excellence in Digital Testing Solutions ...

Best's Capital Adequacy Relativity (BCAR) is a rating of an insurance company’s balance sheet strength. It examines an ...